House Resolution No. [insert number] proposes to designate May 5-9, 2025, as Tardive Dyskinesia Awareness Week in Michigan. The resolution highlights the increasing use of antipsychotic medications for treating serious mental illnesses, which can lead to tardive dyskinesia (TD), a condition characterized by uncontrollable movements. It notes that certain populations, including older adults, women, and individuals with specific mental health conditions, are at a higher risk for developing TD. Alarmingly, around 60% of the estimated 800,000 adults in the U.S. living with TD remain undiagnosed, emphasizing the need for early screening and intervention.

The resolution calls for increased awareness and education regarding TD among healthcare providers, patients, and caregivers, advocating for routine screenings as recommended by the American Psychiatric Association. It also acknowledges that FDA-approved treatments are available to help manage symptoms and improve the quality of life for those affected by TD. By declaring this week, the House of Representatives aims to promote understanding of TD's causes and symptoms, as well as the importance of regular screenings for individuals prescribed antipsychotics.